Security key
M47238106
- Security type / class
- Equity / SHS
- Total 13F shares
- 4,813,565
- Total 13F value
- $14,631,600
- Share change
- -849,713
- Put/Call ratio
- 218%
- SEC-reported price per share
- $3.04
- Number of holders
- 24
- Value change
- -$2,729,925
- Number of buys
- 6
- Number of sells
- 17
Open additional details 1 more signal available
Report period
Q2 2021
Institutions
24
Top holders
10
GLMD full security history
Ownership snapshot
Full 13F holder table
Galmed Pharmaceuticals Ltd. SEC filings
Galmed Pharmaceuticals Ltd. company facts
Broader feeds
Ownership snapshot
Top reported holders of GLMD - GALMED PHARMACEUTICALS LTD - SHS (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BVF INC/IL
Disclosed value leader
BVF INC/IL
Comparable rows
0/15
Latest evidence
31 Mar 2021
13F
Highest disclosed value: $6,173,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
BVF INC/IL has the largest disclosed position value at $6.17M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BVF INC/IL's linked filing trail.
Disclosed position value
Top 5
BVF INC/IL
$6.17M
IBEX INVESTORS LLC
$5.23M
Nantahala Capital Management, LLC
$4.16M
P.A.W. CAPITAL CORP
$686K
MORGAN STANLEY
$636K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BVF INC/IL |
13F
Company
|
—
denominator unverified
|
$6,173,000
1,799,694 shares
|
— | 31 Mar 2021 |
| IBEX INVESTORS LLC |
13F
Company
|
—
denominator unverified
|
$5,231,000
1,525,000 shares
|
— | 31 Mar 2021 |
| Nantahala Capital Management, LLC |
13F
Company
|
—
denominator unverified
|
$4,162,000
1,213,540 shares
|
— | 31 Mar 2021 |
| P.A.W. CAPITAL CORP |
13F
Company
|
—
denominator unverified
|
$686,000
200,000 shares
|
— | 31 Mar 2021 |
| MORGAN STANLEY |
13F
Company
|
—
denominator unverified
|
$636,000
185,552 shares
|
— | 31 Mar 2021 |
| BAKER BROS. ADVISORS LP |
13F
Company
|
—
denominator unverified
|
$634,000
184,927 shares
|
— | 31 Mar 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
24
Shares
4,813,565
Rows available
24
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
30
Q2 2021 holders
24
Holder diff
-6
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 value | Q2 2021 value | Value change | Value Chg % |
|---|